Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06618079
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-04-22
Brief Title:
Drug-Drug Interaction Study Between HUC2-565-A and HUC2-565-B
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Two Cohort Single-sequence Parallel Open Label Multiple Oral Dosing Phase 1 Clinical Trial to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of HUC2-565-A and HUC2-565-B in Healthy Adult Volunteers
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate a pharmacokinetic drug interaction and safety
Detailed Description:
Cohort A To evaluate the effect of S-Amlodipine on the pharmacokinetics of Azilsartan at steady state
Cohort B To evaluate the effect of Azilsartan on the pharmacokinetics of S-Amlodipine at steady state
Cohort B To evaluate the effect of Azilsartan on the pharmacokinetics of S-Amlodipine at steady state
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None